Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Alistipes finegoldii: A niche Bacteroidetes specialist
An Alistipes finegoldii test uses DNA sequencing of a stool sample to detect and quantify this specific bacterial species within your gut community. Modern methods such as 16S rRNA gene sequencing can estimate the presence of the Alistipes genus, while metagenomic sequencing (shotgun) measures A. finegoldii at species level with greater precision. Your result is usually reported as a relative abundance (the percentage of total microbial DNA), sometimes alongside absolute counts depending on the lab. Because the gut is dynamic, results represent your current ecosystem snapshot rather than a fixed trait.
Why focus on A. finegoldii? This anaerobic, commensal bacterium is part of the Bacteroidetes phylum and participates in fermenting dietary components to produce metabolites like short‑chain fatty acids (SCFAs). Its levels can shift with diet composition, medications, stress, and illness, and its pattern often mirrors broader microbiome diversity and stability. While research is evolving, looking at A. finegoldii in context helps translate the microbiome’s chemistry into everyday physiology: digestion efficiency, immune tone, and how well the gut barrier stays intact.
What this species reveals about your ecosystem
Connecting a species‑level result to how you feel starts with biology. A. finegoldii lives among thousands of neighbors, interacting through nutrient competition and metabolite exchange. When fiber and resistant starch reach the colon, microbes ferment them into SCFAs that nourish colon cells and help regulate inflammation. A. finegoldii contributes to these networks, and its relative rise or fall can flag shifts in diet (think low‑fiber, high‑animal‑protein patterns), recent antibiotics, or periods of high stress. Testing after notable changes—like a new eating plan, a course of antibiotics, or starting appetite‑altering medications—can clarify whether your ecosystem is trending back toward balance.
Zooming out, the gut microbiome influences glucose handling, lipid metabolism, and immune signaling through compounds such as SCFAs and bile acid derivatives. Regular microbiome testing turns guesswork into pattern recognition: how your unique microbial signature responds to fiber intake, fermented foods, sleep regularity, and stress management. The goal is not to chase a single “good” microbe, but to understand how keystone species like A. finegoldii fit into the bigger picture of prevention and long‑term well‑being, alongside clinical history and other biomarkers.
Reading your A. Finegoldii result
Your report typically shows A. finegoldii as a proportion of total microbes, with comparisons to a reference population. There is no universal “ideal” number; healthy microbiomes vary widely by age, geography, and diet. In general, balanced ecosystems display higher microbial diversity and a robust representation of fiber‑fermenting organisms. When A. finegoldii appears within a diverse community and alongside other beneficial genera (for example, Bifidobacterium and Faecalibacterium), it often reflects a well‑functioning fermentation network that supports SCFA production and a calm immune environment.
When results suggest balance, the physiology tends to look like this: efficient fermentation of complex carbohydrates into SCFAs (acetate, propionate, and butyrate), steadier gut barrier function, and fewer inflammatory signals from bacterial cell components (like lipopolysaccharides) crossing into circulation. In this setting, A. finegoldii is part of the cast—not the star—signaling that your microbial community has the range to digest, synthesize, and recycle nutrients effectively.
When results suggest imbalance, you might see very low A. finegoldii within an overall low‑diversity community, or an out‑of‑proportion rise alongside other changes that point to dietary monotony, recent antibiotics, or increased bile acid exposure. These patterns are not diagnoses. They are functional clues that the ecosystem could benefit from restoring substrate availability for fermentation (the kind your microbes use to make SCFAs) or reducing stressors that disrupt microbial stability. If symptoms persist—such as frequent bloating, irregular stools, or unexplained fatigue—clinicians may pair microbiome findings with inflammation markers, iron studies, or metabolic labs to refine the differential.
Test 150+ biomarkers
Two blood draws. A full picture of your health, explained in plain language.
Test 150+ biomarkers
Two blood draws. A full picture of your health, explained in plain language.
Caveats that shape interpretation
A few practical nuances help you interpret the data responsibly. Different assays vary in resolution: 16S rRNA methods often identify to genus, while shotgun metagenomics can reliably quantify A. finegoldii to species. Relative abundance can shift simply because another group expanded or contracted, so trends over time and diversity metrics add context. Stool reflects the luminal compartment rather than the mucosal layer, which means some niche organisms may be under‑represented. Recent antibiotics, colonoscopy prep, acute gastroenteritis, or major diet changes can transiently alter readings; it is wise to consider timing when comparing results. Cross‑lab methods and databases also differ, so absolute numbers may not be directly comparable between vendors.
Using A. Finegoldii as a directional signal
Where does this leave you? With a clearer map. An Alistipes finegoldii test helps translate your diet and lifestyle into measurable microbial patterns, and those patterns into mechanisms you can understand: fermentation capacity, bile acid handling, and immune tone. Evidence continues to grow, and findings should be viewed as directional rather than definitive. When combined with your story, symptoms, and other labs, A. finegoldii becomes a useful compass for personalizing digestion, energy, and long‑term gut resilience—tracked over time rather than judged on a single snapshot.
Frequently Asked Questions
References
- Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A (2020). The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. *Frontiers in Immunology*, *11*, 906. https://doi.org/10.3389/fimmu.2020.00906
- Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. *Cell*, *165*(6), 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
- Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A (2021). Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. *Scientific Reports*, *11*, 3030. https://doi.org/10.1038/s41598-021-82726-y
- Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *The New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Gasbarrini A, Segata N, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X
Heart & Vascular Health
Metabolic Health
Energy
Liver Health
Kidney
Sex Hormones
Thyroid Health
Nutrients
Immune System
Inflammation